16.06.2017
- US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...
12.06.2017
- UK biotech Glythera has launched a project to develop next-generation antibody drug conjugates (ADCs) for difficult-to-treat tumors, backed by funding of £1 million from government...
09.05.2017
- US healthcare giant Johnson & Johnson (J&J) has said it will appeal the verdict of a jury in St. Louis, Missouri, ordering the company to pay more than $110 million in damages to a...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
27.04.2017
- The US Food and Drug Administration (FDA) has sent warning letters to 14 US-based companies it accuses of illegally selling more than 65 products fraudulently claiming to prevent...
24.04.2017
- After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid...
21.04.2017
- US pharmaceutical companies Bristol-Myers Squibb and Apexigen are collaborating to test a combination of their respective drugs to treat patients with advanced solid tumors...
08.03.2017
- After losing three earlier lawsuits alleging that its talc powder caused ovarian cancer – which cost it nearly $200 million in damages – US healthcare giant Johnson & Johnson (J&J)...